Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADAPT trial in early breast cancer
2011-001462-17Phase 2Completed
- Sponsor
- Westdeutsche Studiengruppe
- Start
- Oct 2011
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of epirubicin, cyclophosphamide, paclitaxel, tamoxifen, anastrozole and 8 more in breast cancer, sponsored by Westdeutsche Studiengruppe. Started Oct 2011; status: completed.
02
Drugs
epirubicincyclophosphamidepaclitaxeltamoxifenanastrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2011-001462-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001462-17.